Synlett 2005(9): 1409-1412  
DOI: 10.1055/s-2005-869837
LETTER
© Georg Thieme Verlag Stuttgart · New York

Ionic Liquid Promoted Aza-Diels-Alder Reaction of Danishefsky’s Diene with Imines

Bruce Pégot, Giang Vo-Thanh*
Laboratoire des Réactions Sélectives sur Supports, ICMMO, CNRS UMR 8615, Université Paris-Sud, 91405 Orsay Cedex, France
Fax: 33(1)69154679; e-Mail: gvothanh@icmo.u-psud.fr;
Further Information

Publication History

Received 25 February 2005
Publication Date:
10 May 2005 (online)

Abstract

A highly efficient procedure for the synthesis of 2-substituted-2,3-dihydro-4-pyridone derivatives through the aza-Diels-Alder reaction under ‘green chemistry’ conditions is described. The reaction of Danishefsky’s diene with imines has been found to ­perform better at room temperature in ionic liquids without an acid catalyst and organic solvent: the ionic liquids are recycled while their efficiency is preserved.

15

General Procedure for the Aza-Diels-Alder Reaction of Danishefsky’s Diene with Imines A mixture of imine 2 (1 mmol), ionic liquid (0.5 equiv) and Danishefsky’s diene 1 (1.2 equiv added in two phases) was stirred at 30 °C for the period of time reported in Table [3] . The reaction mixture was extracted from the ionic liquid phase with Et2O (3 × 10 mL). The ether layer was dried over anhydrous MgSO4 and evaporated under reduced pressure. The residue was purified by flash column chromatography (EtOAc-pentane, 10:90→70:30) to provide 3.
The ionic liquid was dissolved in CH2Cl2 (20 mL) and then recycled by washing with H2O (2 × 10 mL). The organic phase was dried over anhydrous MgSO4, filtered and evaporated in vacuo to afford the recycled ionic liquid. Spectra data (IR, 1H and 13C) were identical to the initial ionic liquid sample. This was reused without loss of efficiency (Table [3] , entry 1).
1-Benzyl-2,3-dihydro-2-phenylpyridin-4(1 H )-one (3a) IR (neat): 2926, 1635, 1591, 1494, 1453, 1382, 1205, 1078, 760, 700 cm-1. 1H NMR (CDCl3): δ = 2.68 (dd, 1 H, J = 8.6 Hz, 16.6 Hz), 2.84 (dd, 1 H, J = 7.2 Hz, 16.6 Hz), 4.12 (d, 1 H, J = 15.5 Hz), 4.35 (d, 1 H, J = 15.5 Hz), 4.50 (t, 1 H, J = 7.2 Hz), 5.10 (d, 1 H, J = 7.9 Hz), 7.13 (d, 1 H, J = 7.2 Hz), 7.24-7.36 (m, 10 H). 13C NMR (CDCl3): δ = 43.2, 57.1, 60.3, 98.2, 126.9, 127.5, 128.1, 129.3, 135.6, 138.2, 154.5, 190.4. HRMS (EI): m/z calcd for C18H17NO (M+), 263.1310; found, 263.1310.
1-Benzyl-2,3-dihydro-2-(4-methoxyphenyl)pyridin-4(1 H )-one (3b) IR (neat): 3050, 1634, 1574, 1514, 1383, 1254, 1030, 833, 739, 699 cm-1. 1H NMR (CDCl3): δ = 2.63 (dd, 1 H, J = 8.8 Hz, 16.5 Hz), 2.76 (dd, 1 H, J = 7.0 Hz, 16.8 Hz), 3.78 (s, 3 H), 4.10 (d, 1 H, J = 15.0 Hz), 4.28 (d, 1 H, J = 15.0 Hz), 4.41 (t, 1 H, J = 8.5 Hz), 5.04 (d, 1 H, J = 7.5 Hz), 6.83 (d, 1 H, J = 8.7 Hz), 7.10-7.32 (m, 9 H). 13C NMR (CDCl3): δ = 43.6, 55.3, 57.0, 60.1, 98.4, 114.3, 128.0, 128.6, 128.8, 129.3, 130.4, 135.8, 154.4, 159.5, 190.8. HRMS (EI): m/z calcd for C19H19NO2 (M+), 293.1416; found, 293.1410.

1-Benzyl-2,3-dihydro-2-(4-chlorophenyl)pyridin-4(1 H )-one (3c) IR (neat): 3063, 1644, 1574, 1490, 1382, 1205, 1091, 825, 734, 699 cm-1. 1H NMR (CDCl3): δ = 2.62 (dd, 1 H, J = 8.0 Hz, 16.8 Hz), 2.84 (dd, 1 H, J = 7.4 Hz, 16.6 Hz), 4.10 (d, 1 H, J = 15.2 Hz), 4.38 (d, 1 H, J = 15.2 Hz), 4.47 (t, 1 H, J = 7.4 Hz), 5.10 (d, 1 H, J = 8.0 Hz), 7.12 (d, 1 H, J = 8.2 Hz), 7.15-7.35 (m, 9 H). 13C NMR (CDCl3): δ = 43.3, 57.3, 59.7, 98.6, 127.6, 128.3, 128.9, 135.4, 136.8, 136.9, 154.2, 190.0. HRMS (EI): m/z calcd for C18H16ClNO (M+), 297.0920; found, 297.0910.
1-Benzyl-2,3-dihydro-2-(4-nitrophenyl)pyridin-4(1 H )-one (3d) Mp 104 °C. IR (neat): 3032, 1711, 1645, 1582, 1516, 1455, 1347, 1206, 1157, 1030, 856, 734, 699 cm-1. 1H NMR (CDCl3): δ = 2.60 (dd, 1 H, J = 6.8 Hz, 16.6 Hz), 2.93 (dd, 1 H, J = 7.2 Hz, 16.2 Hz), 4.12 (d, 1 H, J = 15.2 Hz), 4.44 (d, 1 H, J = 15.2 Hz), 4.61 (t, 1 H, J = 7.2 Hz), 5.13 (d, 1 H, J = 8.0 Hz), 7.12-7.45 (m, 9 H), 8.22 (d, 1 H, J = 9.0 Hz). 13C NMR (CDCl3): δ = 42.8, 57.8, 59.5, 99.2, 124.2, 128.1, 128.3, 129.0, 129.6, 135.1, 145.7, 147.7, 153.9, 189.0. HRMS (EI): m/z calcd for C18H16N2O3 (M+), 308.1161; found, 308.1154.
1-Benzyl-2,3-dihydro-2-hexylpyridin-4(1 H )-one (3e) IR (neat): 2931, 1710, 1574, 1558, 1455, 1352, 1195, 1136, 1061, 970, 740, 699 cm-1. 1H NMR (CDCl3) δ = 0.88 (t, 3 H, J = 5.7 Hz), 1.26 (m, 6 H), 1.62 (m 2 H), 1.78 (m, 2 H), 2.31 (dd, 1 H, J = 3.0 Hz, 16.5 Hz), 2.69 (dd, 1 H, J = 7 Hz, 16.5 Hz), 3.4 (m, 1 H), 4.35 (d, 1 H, J = 15.2 Hz), 4.43 (d, 1 H, J = 15.2 Hz), 4.95 (d, 1 H, J = 7.5 Hz), 7.06 (d, 1 H, J = 7.5 Hz), 7.27-7.45 (m, 5 H). 13C NMR (CDCl3): δ = 14.0, 22.5, 25.5, 28.4, 29.1, 31.6, 39.0, 56.0, 58.0, 96.8, 127.4, 127.8, 128.3, 129.1, 136.4, 153.4, 191.1. HRMS (EI): m/z calcd for C18H25NO (M+), 271.1936; found, 271.1942.
1-Benzyl-2,3-dihydro-2-isobutylpyridin-4(1 H )-one (3f) IR (neat): 2960, 1710, 1622, 1575, 1558, 1455, 1352, 1195, 1137, 1059, 970, 738, 699 cm-1. 1H NMR (CDCl3): δ = 0.80 (d, 3 H, J = 6.5 Hz), 0.93 (d, 3 H, J = 6.5 Hz), 1.60 (m, 2 H), 1.79 (m, 1 H), 2.27 (dd, 1 H, J = 3.3 Hz, 16.5 Hz), 2.70 (dd, 1 H, J = 6.7 Hz, 16.7 Hz), 3.5 (m, 1 H), 4.32 (d, 1 H, J = 15.3 Hz), 4.42 (d, 1 H, J = 15.3 Hz), 4.96 (d, 1 H, J = 7.2 Hz), 7.07 (d, 1 H, J = 6.8 Hz), 7.27-7.41 (m, 5 H). 13C NMR (CDCl3): δ = 21.3, 23.4, 24.1, 36.5, 38.3, 53.9, 58.1, 96.0, 127.6, 128.4, 129.1, 136.0, 154.5, 191.3. HRMS (EI): m/z calcd for C16H21NO (M+), 243.1623; found, 243.1622.
1-Benzyl-2,3-dihydro-2-isopropylpyridin-4(1 H )-one (3g) IR (neat): 2965, 1713, 1634, 1568, 1558, 1455, 1353, 1195, 1137, 1059, 973, 735, 700 cm-1. 1H NMR (CDCl3): δ = 0.95 (d, 6 H, J = 6.2 Hz), 2.27 (m, 1 H), 2.40 (dd, 1 H, J = 3.5 Hz, 17.0 Hz), 2.63 (dd, 1 H, J = 7.7 Hz, 17.0 Hz), 3.25 (m, 1 H), 4.40 (d, 1 H, J = 15.2 Hz), 4.50 (d, 1 H, J = 15.2 Hz), 4.95 (d, 1 H, J = 7.0 Hz), 7.17-7.40 (m, 6 H), 13C NMR (CDCl3): δ = 17.8, 19.4, 29.0, 35.4, 58.9, 61.0, 96.5, 127.4, 128.4, 129.1, 136.2, 155.8, 192.1. HRMS (EI): m/z calcd for C15H19NO (M+), 229.1467; found, 229.1472.